Author: A4L Admin

Posted at 22 Mar, 17:22h in Heart Failure by A4L Admin

3 Likes

Machine learning: at the heart of failure diagnosis

04 Mar CorVista Health Completes $65 Million Series C Equity Raise Bringing Total Funding to Nearly $100 Million

Posted at 08:01h in Press Release by A4L Admin

3 Likes

[vc_row css_animation="" row_type="row" use_row_as_full_screen_section="no" type="full_width" angled_section="no" text_align="left" background_image_as_pattern="without_pattern"][vc_column][vc_column_text]Funding to Fuel Development and Commercialization Efforts for Non-Invasive Diagnostic System to Assess for Heart Disease TORONTO, ON, March 4, 2021 — CorVista Health, Inc., a digital health company dedicated to improving cardiovascular disease diagnosis, today announced it has...

Read More

Posted at 24 Feb, 21:17h in Coronary Artery Disease by A4L Admin

1 Like

Predicting cardiac disease from interactions of simultaneously-acquired hemodynamic and cardiac signals

Posted at 24 Feb, 21:15h in Heart Failure by A4L Admin

1 Like

Predicting cardiac disease from interactions of simultaneously-acquired hemodynamic and cardiac signals

16 Dec Analytics 4 Life® Rebrands as CorVista® Health; Appoints Scott Burger as Chief Commercial Officer and Vice President

Posted at 08:15h in Press Release by A4L Admin

1 Like

[vc_row css_animation="" row_type="row" use_row_as_full_screen_section="no" type="full_width" angled_section="no" text_align="left" background_image_as_pattern="without_pattern"][vc_column][vc_column_text]Company Advancing Proprietary Machine Learning to Improve Care in Cardiology TORONTO, ON, December 16, 2020 — Analytics 4 Life today announced the appointment of Scott Burger to Chief Commercial Officer and Vice President. Scott will lead the commercialization efforts...

Read More